Skip to content
Lower risk Drug recall · FDA · Published September 15, 2026

Clear Eyes Eye Drops Recall: Lack of Sterility Risk

Insight Pharmaceuticals recalls Clear Eyes Redness Relief eye drops due to lack of assurance of sterility. Affected lots may cause eye infections. Consumers should stop using and contact the company.

🇺🇸 FDA recall #D-0871-2026DrugInsight Pharmaceuticals ›
✎ GovInfoNow plain-language explainer

Insight Pharmaceuticals is recalling Clear Eyes Redness Relief eye drops because they may not be sterile. Using these drops could lead to eye infections, especially if the product is not properly cleaned or handled. Read more at govinfonow.com/recall/1287564-clear-eyes-eye-drops-recall-lack-of-sterility-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/1287564-clear-eyes-eye-drops-recall-lack-of-sterility-risk · Updated October 6, 2026 · FDA enforcement record: FDA #D-0871-2026

Cite this page

“Clear Eyes Eye Drops Recall: Lack of Sterility Risk.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/1287564-clear-eyes-eye-drops-recall-lack-of-sterility-risk. Based on FDA recall #D-0871-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0871-2026%22&limit=1).

The FDA announced on 2026-09-15 that Insight Pharmaceuticals LLC is voluntarily recalling Clear Eyes Redness Relief eye drops due to a lack of sterility assurance. The recall affects specific lots distributed nationwide.

How to tell if you have it

  • Brand: Insight Pharmaceuticals
  • Product: Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%)
  • NDC: 67172-797-15
  • Lot #: RL25G04, Exp. Date 07/2027
  • Lot #: RL2H02, Exp. Date 08/2027
  • Size: 0.5 fl oz (15mL)
  • Distribution: Nationwide in the USA

The hazard

The recall is due to a lack of assurance of sterility in the eye drops, according to the FDA.

Context

GovInfoNow's records show Insight Pharmaceuticals LLC has 2 other recalls on record since 2023-12-21. Other recent recalls of similar products include Clear Eyes Eye Drops Recalled for Sterility Risk (2026-07-29), K.C. Pharmaceuticals Ultra Lubricating Eye Drops Recall: Lack of Sterility Risk (2026-03-03) and K.C. Pharmaceuticals Dry Eye Relief Eye Drops Recall: Lack of Sterility Assurance (2026-03-03).

How to tell if you have this one

Check the product label for the lot numbers RL25G04 (expiring 07/2027) or RL2H02 (expiring 08/2027). The product is a 0.5 fl oz eye drop bottle with a hang tag.

  • Brand
    Insight Pharmaceuticals
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Nationwide in the USA.
Recall numberProduct, codes & lotsQuantity
D-0870-2026Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15; Lot #: RL25G02, RL25G03, RL25G04, Exp. Date Jul-27; RL25H02, RL25H03, RL25H04, Exp. Date Aug-27; RL25K01, RL25K02, RL25K03, RL25K04, Exp. Date Sep-27; RL25M01, RL25M02, RL25M03, RL25M04, Exp. Date Oct-27; RL25N01, RL25N02, RL25N04, Exp. Date Nov-27.2,356,248 bottles
D-0871-2026Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15; Lot #: RL25G04, Exp. Date 07/2027; RL2H02, Exp. Date 08/2027.—
Based on the official FDA remedy

What to do — step by step

  1. Stop Using the Drops

    Discard the affected eye drops immediately to prevent potential eye infections.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 15 days after the firm started it.

1. Firm started the recall: Sep 15, 202612. FDA classified it Class II: Sep 23, 202623. Published in FDA’s Enforcement Report: Sep 30, 202634. Added to GovInfoNow: Oct 6, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0871-2026 (September 15, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0871-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA